PATENT CLAIM ANALYSIS

Application Number: 15759723
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["424", "085200"]

Abstract:
This disclosure describes an adaptive NK cell, an isolated population of adaptive Natural Killer (NK) cells, a composition including an adaptive NK cell, and methods for producing, preparing, and using an adaptive NK cell or an isolated population or composition including an adaptive NK cell. The adaptive NK cells may be used to treat a viral infection or a tumor.

Claim (Index 57):
The method of  claim 56 , wherein the method comprises\n (i) deriving the adaptive NK cell from a cytomegalovirus (CMV) na\u00efve source; (ii) deriving the adaptive NK cell from a cell isolated from blood, a pluripotent stem cell, an induced pluripotent stem cell, an embryonic stem cell, or a cell isolated from umbilical cord blood; (iii) deriving the adaptive NK cell from cells cultured in a culture medium comprising at least one of IL-15, IL-21, IL-18, IL-12, IL-2, IFN-\u03b1, and IFN-\u03b2; or (iv) deriving the adaptive NK cell from cells cultured in a culture medium comprising at least one of rapamycin, a Notch ligand, an NKG2C receptor agonist, a monocyte, an antigen presenting cell, a dendritic cell, and a CMV peptide.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 90.0
- Lexical Diversity: 1.91667
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12855203', '13865762', '13946266', '14547084', '15167166']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6725334546382099
- 35 USC 102 Novelty (BERT): 0.5351157424734111
- Combined Prediction Score: 0.65879168342173
- Mean Citation Score: 332.60156
- Max Citation Score: 374.96857
- Similarity Product: 282.02907832445203

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test